Ann Esquivel is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 265 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4400 Weston Pointe Dr Ste 150
Zionsville, IN 460777205
Telephone
317-732-4046Provider last certified this registry record 12 Mar 2021.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- HOSPIRA, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
81.2%Corticosteroid29.5%Fluticasone Propionate37%Arnuity Ellipta13%Symbicort13%Trelegy Ellipta9%Budesonide-Formoterol Fumarate9%Breo Ellipta8%Dulera7%Pulmicort Flexhaler5%Part D<11 patientsLeukotriene Receptor Antagonist24.8%Montelukast Sodium100%Part D≥68 patients+ 5 more classes in this area
Metabolism & gastrointestinal
15.5%H2 blocker9.1%Famotidine100%Part D≥26 patientsProton pump inhibitor3.3%Omeprazole100%Part D<11 patients+ 1 more class in this area
Anti-infectives
1.9%Macrolide Antimicrobial1.9%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma
American Journal of Respiratory and Critical Care Medicine
2017 - Anaphylaxis Conundrum: A Trojan Horse Phenomenon
The Journal of Allergy and Clinical Immunology In Practice
2016 - Multisystem reactions during egg oral food challenges may be associated with less severe reactions on initial presentation
Allergy Asthma and Clinical Immunology
2016 - Omalizumab Decreases Rates of Cold Symptoms in Inner-City Children with Allergic Asthma
Journal of Allergy and Clinical Immunology
2016 - Multisystem reactions during egg oral food challenges may be associated with less severe reactions on initial presentation
PMC
2016
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”